Avalo Therapeutics, Inc. (AVTX)
NASDAQ:AVTX
Want to see AVTX full AI Analyst Report?
Avalo Therapeutics (AVTX) Ownership Overview
0.25% Insiders
2.26% Mutual Funds
40.95% Other Institutional Investors
1.68% ETFs
54.86% Public Companies and
Individual Investors
The ownership structure of Avalo Therapeutics (AVTX) stock is a mix of institutional, retail, and individual investors. Approximately 44.89% of the company’s stock is owned by Institutional Investors, 0.25% is owned by Insiders, and 54.86% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 18, 2026 | xxxxxxxxxxxxx | $411441 | |
Nov 17, 2025 | xxxxxxxxxxxxx | $162876 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2024 | xxxxxxxxxxxxx | $13675880 | |
Sep 30, 2024 | xxxxxxxxxxxxx | $448512 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 916,000 | Institution | 1.74% | 14,903,320 | |
| 701,070 | Institution | 1.33% | 11,406,409 | |
| 693,421 | Institution | 1.32% | 11,281,960 | |
| 662,968 | Institution | 1.26% | 10,786,489 | |
| 220,300 | Institution | 0.42% | 3,584,281 | |
| 139,667 | Institution | 0.27% | 2,272,382 | |
| 132,336 | Institution | 0.25% | 2,153,107 | |
| 132,036 | Institution | 0.25% | 2,148,226 | |
| 103,922 | Institution | 0.20% | 1,690,811 | |
| 90,114 | Insider | 0.17% | 1,466,155 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 693,421 | Institution | 1.32% | 11,281,960 | |
| 220,300 | Institution | 0.42% | 3,584,281 | |
| 132,336 | Institution | 0.25% | 2,153,107 | |
| 103,922 | Institution | 0.20% | 1,690,811 | |
| 10,852 | Institution | 0.02% | 176,562 | |
| 7,772 | Institution | 0.01% | 126,450 | |
| 6,000 | Institution | 0.01% | 97,620 | |
| 5,197 | Institution | <0.01% | 84,555 | |
| 3,002 | Institution | <0.01% | 48,843 | |
| 1,694 | Institution | <0.01% | 27,561 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 537,792 | Institution | 1.02% | 8,029,235 | |
| 163,278 | Institution | 0.31% | 2,437,741 | |
| 83,011 | Institution | 0.16% | 1,655,239 | |
| 48,244 | Institution | 0.09% | 961,985 | |
| 27,018 | Institution | 0.05% | 547,115 | |
| 9,276 | Institution | 0.02% | 187,839 | |
| 6,829 | Institution | 0.01% | 119,508 | |
| 6,464 | Institution | 0.01% | 130,896 | |
| 781 | Institution | <0.01% | 15,815 | |
| 430 | Institution | <0.01% | 8,725 |
FAQ
Who Owns Avalo Therapeutics, Inc. (AVTX)?
According to the latest TipRanks data, approximately 40.95% of the company's stock is held by institutional investors, 0.25% is held by insiders, and 54.86% is held by retail investors.
What percentage of Avalo Therapeutics, Inc. (AVTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 40.95% of Avalo Therapeutics, Inc. (AVTX) stock is held by institutional investors.
What percentage of Avalo Therapeutics, Inc. (AVTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 54.86% of Avalo Therapeutics, Inc. (AVTX) stock is held by retail investors.
Who owns the most shares of Avalo Therapeutics, Inc. (AVTX)?
Andrew J.M. Spokes owns the most shares of Avalo Therapeutics, Inc. (AVTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.